Metabolomic analysis of the effects of phenylbutyrate (PB) in patients with myalgic encephalomyelitis/chronic fatigue syndrome (me/CFS)
Active Purchase Order Awarded Last action
- Contract number
- 75N98026P01474
- Awardee
-
Metabolon, Inc. UEI SBY5A7EK9PU3
- Awarding agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Obligated
- $41,400
Award facts
- Opportunity
-
- Metabolomic Analysis of the Effects of Phenylbutyrate (PB) in Patients with Mya Special Notice · 75N98026Q01076 · Posted Sep 1, 2026
- Contract value 100% obligated
- $41,400.00 Current and potential, with all options
- Completion date 8% complete
- Current and potential, with all options
- Funding agency
- National Heart Lung and Blood Institute National Institutes of Health, Department of Health and Human Services
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Morrisville, NC, USA
Award details come from SAM.gov/FPDS.
About this award
The National Heart, Lung and Blood Institute awarded a purchase order to Metabolon, Inc. valued at $41,400 on September 30, 2026 for metabolomic analysis of phenylbutyrate effects in myalgic encephalomyelitis/chronic fatigue syndrome patients.
Work is performed in Morrisville, North Carolina. The order calls for untargeted metabolomic profiling and bioinformatic analysis of 75 plasma samples from 30 ME/CFS patients at baseline and after eight weeks of sodium phenylbutyrate treatment, plus 15 healthy control samples. Metabolon will conduct three comparative analyses: baseline ME/CFS versus healthy controls, post-treatment versus baseline ME/CFS, and post-treatment ME/CFS versus healthy controls. The base performance period runs from September 30, 2026 through September 29, 2027. This procurement was non-competitive, justified by the requirement for analytical continuity with Metabolon's existing ME/CFS dataset to avoid methodological variability and preserve scientific validity.
Quick answers
Who was awarded contract 75N98026P01474?
75N98026P01474 was awarded to Metabolon, Inc. by Office of Logisitics and Acquisition Operations (National Institutes of Health) on September 30, 2026.
How much is contract 75N98026P01474 worth?
The government has obligated $41,400 on 75N98026P01474.
Which agency awarded contract 75N98026P01474?
Office of Logisitics and Acquisition Operations (National Institutes of Health) awarded 75N98026P01474, with funding from National Heart Lung and Blood Institute (National Institutes of Health).
Was contract 75N98026P01474 competed?
The extent of competition for 75N98026P01474 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award